http://blog.newtbdrugs.org Working Towards a Faster Cure for Tuberculosis Fri, 30 Jul 2010 19:19:42 +0000 http://wordpress.org/?v=2.9.1 en hourly 1 WorkingGroupOnNewTBDrugsBloghttp://feedburner.google.com http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/g80K471nKRM/ http://blog.newtbdrugs.org/2010/07/interview-with-dr-lee-reichman/#comments Fri, 30 Jul 2010 19:16:25 +0000 Working Group http://blog.newtbdrugs.org/?p=1340 This is part one of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.]]> http://blog.newtbdrugs.org/2010/07/interview-with-dr-lee-reichman/feed/ 0 http://blog.newtbdrugs.org/2010/07/interview-with-dr-lee-reichman/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/sWM7D3YvOak/ http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-july-27-2010/#comments Tue, 27 Jul 2010 15:03:04 +0000 Working Group http://blog.newtbdrugs.org/?p=1335 The route of drug delivery for TB drugs is an interesting one with the usual (and valuable) room for debate about different methods. While the standard mode of delivery for most drugs is oral, there is ongoing discussion as to whether aerosol delivery of TB drugs may be a more suitable route of delivery for treating pulmonary TB.]]> http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-july-27-2010/feed/ 0 http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-july-27-2010/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/muXUCMreWT8/ http://blog.newtbdrugs.org/2010/07/women-tb-patients-face-bias-and-violence/#comments Fri, 23 Jul 2010 20:40:50 +0000 Working Group http://blog.newtbdrugs.org/?p=1327 Eight months into her marriage, Rose Joseph (21, name changed) was diagnosed with tuberculosis (TB) in January. Joseph was hospitalised for a week but when she was discharged, her husband asked her to stay at her parents’ place in Malad, saying he and his family had to travel for a wedding. For two weeks, her husband did not call to check on her. When her mother took her to her husband’s home, her mother-in-law said they didn’t want her in the house because she had TB. “My husband wasn’t even ready to face me. My mattress, bedsheets and other belongings had been burned,” said Joseph.]]> http://blog.newtbdrugs.org/2010/07/women-tb-patients-face-bias-and-violence/feed/ 0 http://blog.newtbdrugs.org/2010/07/women-tb-patients-face-bias-and-violence/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/WxEw3v-Qf0c/ http://blog.newtbdrugs.org/2010/07/vienna-2010-citizen-news-service-correspondent-statement-on-ipt/#comments Fri, 23 Jul 2010 15:11:47 +0000 Working Group http://blog.newtbdrugs.org/?p=1321 Citizen News Service correspondent, Bobby Ramakant, reiterates the call from the Stop TB Working Group on TB/HIV to introduce Isoniazid prevention therapy to prevent the progression of latent TB infection to active disease. Effective IPT treatment reduces the development of active TB disease in 40-60% of patients. The content of this post originally appeared in an email sent to the Stop TB Health Dev mailing list.]]> http://blog.newtbdrugs.org/2010/07/vienna-2010-citizen-news-service-correspondent-statement-on-ipt/feed/ 0 http://blog.newtbdrugs.org/2010/07/vienna-2010-citizen-news-service-correspondent-statement-on-ipt/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/10w4CnrbRrU/ http://blog.newtbdrugs.org/2010/07/tag-2010-pipeline-report/#comments Thu, 22 Jul 2010 14:10:35 +0000 Working Group http://blog.newtbdrugs.org/?p=1312 Treatment Action Group (TAG) recently released their TAG 2010 Pipeline Report, an annual report that explores the progress and overall state of drug development in the fields of HIV, Tuberculosis, and Viral Hepatitis. The report covers the development of drugs, diagnostics, vaccines, immune-based therapies, and preventative technologies in development in each field.]]> http://blog.newtbdrugs.org/2010/07/tag-2010-pipeline-report/feed/ 0 http://blog.newtbdrugs.org/2010/07/tag-2010-pipeline-report/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/DznbUvNIoaI/ http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-july-20-2010/#comments Tue, 20 Jul 2010 16:09:32 +0000 Working Group http://blog.newtbdrugs.org/?p=1293 On Friday, July 16th, the fourth annual New England TB Symposium took place at the Broad Institute, in Cambridge, Massachusetts.  The symposium was in collaboration with the US-Japan Cooperative Medical Sciences Program: 45th Tuberculosis and Leprosy Research Conference which preceded the symposium at the Broad from July 13-15th. A brief synopsis of some of the symposium [...]]]> http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-july-20-2010/feed/ 0 http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-july-20-2010/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/5XlVnrBMOPI/ http://blog.newtbdrugs.org/2010/07/the-sanatorium-files-part-4-dots/#comments Thu, 15 Jul 2010 13:02:26 +0000 Working Group http://blog.newtbdrugs.org/?p=1282 Connecting the DOTS: Unprecedented Approach to Ensure Compliance. This is the fourth in our series “The Sanatorium Files.” We round out the series with this post on the most recent development in the treatment of TB: an unusual and unprecedented public health program to ensure compliance with the TB drug regimen called directly observed therapy, short course (DOTS).]]> http://blog.newtbdrugs.org/2010/07/the-sanatorium-files-part-4-dots/feed/ 0 http://blog.newtbdrugs.org/2010/07/the-sanatorium-files-part-4-dots/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/uWQenMnaCZQ/ http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-13-july-2010/#comments Tue, 13 Jul 2010 23:23:32 +0000 Working Group http://blog.newtbdrugs.org/?p=1264 Last week we highlighted the Xpert® MTB/RIF assay for diagnostic testing. This week, we will briefly describe the GenoType® MTBDRplus assay. The GenoType® MTBDRplus assay uses PCR to amplify biotin-labeled amplicons (single-stranded DNA sequences) of M. tb from sputum.]]> http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-13-july-2010/feed/ 0 http://blog.newtbdrugs.org/2010/07/this-week-in-tb-rd-13-july-2010/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/vbMwwyMvDYQ/ http://blog.newtbdrugs.org/2010/07/the-outcasts-of-tuberculosis/#comments Mon, 12 Jul 2010 14:57:47 +0000 Working Group http://blog.newtbdrugs.org/?p=1253 http://blog.newtbdrugs.org/2010/07/the-outcasts-of-tuberculosis/feed/ 1 http://blog.newtbdrugs.org/2010/07/the-outcasts-of-tuberculosis/ http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/ZpfiTicu2kA/ http://blog.newtbdrugs.org/2010/07/dual-infections-of-tb-and-aids-make-each-harder-to-treat/#comments Fri, 09 Jul 2010 19:55:10 +0000 Working Group http://blog.newtbdrugs.org/?p=1238 Tuberculosis infects nearly ten million people each year and kills nearly two million. It is primarily a lung disease that spreads easily among people with weakened immune systems. Sub-Saharan Africa is still the epicenter of the HIV/AIDS disaster, but it is also becoming the epicenter of tuberculosis.]]> http://blog.newtbdrugs.org/2010/07/dual-infections-of-tb-and-aids-make-each-harder-to-treat/feed/ 0 http://blog.newtbdrugs.org/2010/07/dual-infections-of-tb-and-aids-make-each-harder-to-treat/